Insider screener

Period: 12 months Type of trade: Sold × Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20,194 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20,194 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20,194 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20,194 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20,194 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20,194 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20,194 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
23 Apr 2026
Miguel Alvarez Senior Vice President
Sold at will 3×
$1.09M 4,825 at 225.58
3.8%
Not planned
23 Apr 2026
Christopher L Jensen EVP, Chief People Officer
Sold on a plan
$1.07M 4,576 at 234.03
45.9%
Planned (10b5-1)
23 Apr 2026
Alex S Golten Chief Risk Officer
Sold at will 2×
$1.04M 1,116 at 936.18
30.2%
Not planned
23 Apr 2026
Michael Peterson Executive Vice President
Sold at will
$900.00K 10,000 at 90.00
33.2%
Not planned
23 Apr 2026
Gang Ye COO · indirect
Sold on a plan 3×
$834.54K 10,000 at 83.45
3.7%
Planned (10b5-1)
23 Apr 2026
James C Hamilton Chief Medical Officer
Sold on a plan
$750.00K 10,000 at 75.00
4.2%
Planned (10b5-1)
23 Apr 2026
Rebecca Thompson Chief Accounting Officer
Sold at will
$729.93K 7,292 at 100.10
20.9%
Not planned
23 Apr 2026
Edward J Hoffman Sr EVP, General Counsel
Sold on a plan
$540.00K 15,000 at 36.00
10.8%
Planned (10b5-1)
23 Apr 2026
William Abbey Chief Commercial Officer
Sold on a plan
$313.82K 1,577 at 199.00
2.8%
Planned (10b5-1)
23 Apr 2026
Julie Rubinstein President and COO
Sold on a plan
$261.88K 19,060 at 13.74
4.7%
Planned (10b5-1)
23 Apr 2026
Nathan L. Mata Chief Scientific Officer
Sold on a plan 6×
$166.28K 1,000 at 166.28
9.4%
Planned (10b5-1)
23 Apr 2026
Jeffrey A. Reid EVP, Chief HR Officer
Sold at will 2×
$162.63K 1,200 at 135.52
12.9%
Not planned
23 Apr 2026
Ichiro Aoki President
Sold on a plan
$154.03K 43,500 at 3.54
29.1%
Planned (10b5-1)
23 Apr 2026
Patrick John Finn President and COO
Sold at will
$141.03K 2,321 at 60.76
0.8%
Not planned
23 Apr 2026
Bruno Augusto Sacchi Zaremba Pres. Finance and Operations · indirect
Sold on a plan
$113.69K 10,178 at 11.17
0.9%
Planned (10b5-1)
23 Apr 2026
Joseph M. Erlinger President, McDonald's USA
Sold on a plan
$100.81K 333 at 302.72
4.0%
Planned (10b5-1)
23 Apr 2026
Jay S Stout Chief Technology Officer
Sold at will
$81.57K 2,754 at 29.62
1.1%
Not planned
23 Apr 2026
Jingye Chen CPO, Shopee · indirect
Sold on a plan 3×
$66.76K 800 at 83.45
0.4%
Planned (10b5-1)
23 Apr 2026
Yanjun Wang CCO and GC · indirect
Sold on a plan 3×
$66.76K 800 at 83.45
4.4%
Planned (10b5-1)
23 Apr 2026
Fernando Lovisotto Head of Global IP&S · indirect
Sold on a plan
$63.99K 5,734 at 11.16
0.5%
Planned (10b5-1)
23 Apr 2026
Joseph Gates Clark SVP and Pres, Optimized LED
Sold on a plan
$41.02K 1,485 at 27.62
1.6%
Planned (10b5-1)
23 Apr 2026
Ashwath Jayagopal Chief Scientific & Dev. Ofc.
Sold at will
$39.16K 7,542 at 5.19
1.5%
Not planned
23 Apr 2026
Benjamin R Yerxa President
Sold at will
$39.12K 7,470 at 5.24
1.0%
Not planned
23 Apr 2026
Samak L Azar Chief Legal Officer
Sold on a plan
$29.83K 500 at 59.66
2.9%
Planned (10b5-1)
23 Apr 2026
Joseph K Schachle Chief Operating Officer
Sold at will
$24.52K 4,697 at 5.22
1.6%
Not planned
23 Apr 2026
Rabourn Amy Zaremba Head of Fin. Quality Assurance
Sold at will
$8.54K 1,641 at 5.20
0.9%
Not planned
23 Apr 2026
David Chairman SVP, R&D
Sold on a plan
$6.00K 3,600 at 1.67
0.9%
Planned (10b5-1)
23 Apr 2026
Peng Lu Chief Medical Officer also filed by Anne Lesage, Anne Lesage
Sold on a plan
$3.00K 100 at 30.03
0.2%
Planned (10b5-1)
22 Apr 2026
Brian M Venturo Chief Strategy Officer · indirect
Sold on a plan 16×
$9.41M 76,924 at 122.31
100%
Sold half or more
22 Apr 2026
John Colgrove Chief Visionary Officer · indirect
Sold on a plan 6×
$5.80M 82,266 at 70.50
55.1%
Sold half or more
22 Apr 2026
Alexis Le-Quoc Chief Technology Officer
Sold on a plan 4×
$5.66M 43,224 at 130.84
7.5%
Planned (10b5-1)
22 Apr 2026
Sierk Poetting Chief Operating Officer · indirect
Sold on a plan
$5.53M 50,000 at 110.56
11.1%
Planned (10b5-1)
22 Apr 2026
Michelle Zatlyn President and Board Co-Chair · indirect
Sold on a plan 5×
$5.36M 25,641 at 209.15
42.6%
Planned (10b5-1)
22 Apr 2026
Chi Fung Cheng Chief Technology Officer · indirect
Sold on a plan 7×
$5.17M 27,500 at 188.02
0.5%
Planned (10b5-1)
22 Apr 2026
Nathan Blecharczyk Chief Strategy Officer · indirect
Sold on a plan 3×
$3.62M 24,788 at 145.86
67.5%
Sold half or more
22 Apr 2026
Mostapha Tahiri EVP and COO
Sold at will
$1.47M 9,611 at 152.93
12.9%
Not planned
22 Apr 2026
Ari Maizel Chief Commercial Officer
Sold on a plan
$1.37M 7,500 at 182.42
100%
Sold half or more
22 Apr 2026
Gang Ye COO · indirect
Sold on a plan 4×
$859.89K 10,000 at 85.99
3.6%
Planned (10b5-1)
22 Apr 2026
Michael L Richards EVP and Chief Admin Officer
Sold at will
$461.67K 3,000 at 153.89
6.4%
Not planned
22 Apr 2026
William E. Rote Chief Research Officer
Sold on a plan
$355.72K 9,100 at 39.09
7.4%
Planned (10b5-1)
22 Apr 2026
Nicholas Hobbs EVP and COO
Sold at will
$318.95K 1,272 at 250.75
1.4%
Not planned
22 Apr 2026
Julie Rubinstein President and COO
Sold on a plan
$269.32K 19,060 at 14.13
4.7%
Planned (10b5-1)
22 Apr 2026
Anne Lesage Chief Early Development
Sold on a plan 2×
$225.36K 7,500 at 30.05
11.7%
Planned (10b5-1)
22 Apr 2026
Peng Lu Chief Medical Officer
Sold on a plan
$210.40K 7,001 at 30.05
9.6%
Planned (10b5-1)
22 Apr 2026
Anne Lesage Chief Early Development · indirect
Sold on a plan
$210.36K 7,000 at 30.05
4.3%
Planned (10b5-1)
22 Apr 2026
Alistair N Sporck VP Contactor Business Unit · indirect
Sold at will
$186.99K 2,000 at 93.50
27.9%
Not planned
22 Apr 2026
Nathan L. Mata Chief Scientific Officer
Sold on a plan 9×
$170.38K 1,000 at 170.38
8.6%
Planned (10b5-1)
22 Apr 2026
Bruno Augusto Sacchi Zaremba Pres. Finance and Operations · indirect
Sold on a plan
$127.88K 11,521 at 11.10
1.0%
Planned (10b5-1)
Showing 10,301–10,350 of 20,194. ← Newer Page 207 of 404 Older →